NASDAQ
AIM ImmunoTech Inc. (AIM) has a revenue compound annual growth rate of -11.60% over 5 years and -4.05% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.